Bleocin (Bleomycin) 15 mg
Bleocin 15 mg is an antitumor antibiotic, a cytostatic agent. Active ingredient: Bleomycin (15 mg).
Manufacturer: Khandelwal Laboratories (India). Manufactured under technical agreement with Nippon Kayaku (Tokyo, Japan) ๐ฏ๐ต, ensuring high quality.
Key Feature:
Unlike most chemotherapy, Bleomycin causes minimal bone marrow suppression. It has minimal impact on white blood cell and platelet levels. This allows it to be combined with other drugs without the risk of destroying the patient's immunity.
โ Result: High efficacy in treating testicular cancer and lymphomas while preserving blood cell production.
Used primarily in combination therapy regimens:
- Testicular Cancer: Germ cell tumors (in BEP regimen).
- Lymphomas: Hodgkin's lymphoma and Non-Hodgkin's lymphoma (in ABVD regimen).
- Squamous Cell Carcinoma: Head and neck, cervix, skin, external genitalia.
- Malignant Pleural Effusion: To prevent fluid accumulation in the lungs (sclerotherapy).
Form: Powder for injection in a vial (15 mg).
โ ๏ธ For medical professional use only!
Administered intravenously, intramuscularly, or subcutaneously.
- Dosage is calculated by the doctor based on body surface area.
- Critically Important: There is a maximum cumulative dose (usually 400 mg per lifetime). Exceeding this limit causes irreversible lung damage.
- Lung Diseases: Acute infections or pulmonary fibrosis.
- Hypersensitivity to Bleomycin.
- Severe renal impairment.
- Pregnancy and breastfeeding period.
Specific bodily reactions:
- ๐ซ Lungs (Main Risk): Pneumonitis and fibrosis. Any cough or shortness of breath requires immediate examination.
- Skin: Darkening of the skin (hyperpigmentation), thickening, appearance of stripes on the body.
- Fever: Rise in temperature a few hours after injection.
- โ Feature: Usually causes significantly less hair loss than other cytostatics.
What Customers Say
No reviews yet
Your review can be the first!